Opioid as codeine, has similarly demonstrated little benefit in several recent studies.) Low dose morphine may help chronic cough but its use is limited by side effects. In cases of diarrhea-predominate irritable bowel syndrome, opioids may be used to suppress diarrhea. Loperamide is a peripherally selective opioid available without a prescription used to suppress diarrhea. The ability to suppress diarrhea also produces constipation when opioids are used beyond several weeks. Naloxegol, a peripherally-selective opioid antagonist is now available to treat opioid induced constipation. Opioids may help with shortness of breath particularly in advanced diseases such as cancer and COPD among others.
Loperamide first clinical reports on loperamide were published in 1973 in the" Journal of Medicinal Chemistry" with the inventor being one of the authors. The trial name for it was "R-18553". Loperamide oxide has a different research code: R-58425. The trial against placebo was conducted from December 1972 to February 1974, its results being published in 1977 in "Gut", an edition of British Society of Gastroenterology. In 1973, Janssen started to promote loperamide under the brand name Imodium. In December 1976, Imodium got US FDA approval. During the 1980s, Imodium became the best-selling prescription antidiarrheal in the United States. In March